| The protein kinase C family for the regulation of cellular functions | |
| Yoshiki Iwamoto, Hiroshi Koide, Kouji Ogita, Yasutomi Nishizuka | 1-6 |
| The role of cell-matrix interactions in atherosclerosis | |
| Michael Thie, Horst Robenek | 7-12 |
| A paradigm for restenosis after angioplasty: clues for the development of new preventive therapies | |
| James S. Forrester, Michael C. Fishbein, Richard H. Helfant, James A. Fagin | 13-24 |
| An overview of experimental autogenous vein grafts | |
| John K. McGeachie, Marc Tennant | 25-32 |
| Studies and perspectives of plasminogen activators | |
| Michael Steiner, Christine Burstein, Olaf Anders, B. Ernst | 33-38 |
| Endothelium-derived biologically active substance: von Willebrand factor and endothelin | |
| Krikor Dikranian | 39-45 |
| The fungal etiology of gout and hyperuricemia: the antifungal mode of action of colchicine | |
| A. V. Costantini | 47-52 |
| Isolated chondrons: a concept comes of age! | |
| C. Anthony Poole | 53-62 |
| Natural selection and asymmetry: the points of intersection | |
| George B. Karev | 63-68 |
| Calpain: a new matrix proteinase? | |
| Katsuji Shimizu | 69-72 |